Kelyniam Global Inc. (OTC: KLYG) (“the company”) is pleased to announce that it has posted its first ever quarterly profit, for the quarter ending June 30, 2013. Net income for the second quarter was $6,608. Sales in the second quarter were $593,355, up 35% from $438,415 in the first quarter 2013. Year to date sales were $1,031,770, up 253% from the same period in 2012.
The company continues to deploy capital towards marketing and organic growth, and to build market share as its customized PEEK implants are sold in more hospitals than ever. It has recently negotiated better terms for the DECD note secured last year, with the term of the note changing from 5 years to 10 without any increase in the interest rate.
Kelyniam will be an active participant in the Connecticut Economic Trade Mission to Australia later this week, traveling to both Sydney and Canberra, Australia. President & CEO Tennyson Anthony exclaimed, “While we are pleased with our second quarter performance, it is our goal to be used in all 50 states and internationally as well.” He continued, “In fact, our growth is not only focused on geography, but on building on our existing products. The company will be announcing a new product in the months to come, one that we feel will turn heads.”